Therapeutic drug monitoring for isoniazid and rifampicin exposure

被引:1
作者
Peloquin, C. A. [1 ]
机构
[1] Univ Florida, Coll Pharm, POB 100486,1600 SW Archer Rd, Gainesville, FL 32610 USA
关键词
isoniazid; rifampin; drug exposure; therapeutic drug monitoring;
D O I
10.5588/ijtld.23.0495
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:168 / 169
页数:2
相关论文
共 50 条
  • [31] HEPATOTOXICITY CAUSED BY THE COMBINED ACTION OF ISONIAZID AND RIFAMPICIN
    ASKGAARD, DS
    WILCKE, T
    DOSSING, M
    THORAX, 1995, 50 (02) : 213 - 214
  • [33] Stability of rifampicin in dissolution medium in presence of isoniazid
    Shishoo, CJ
    Shah, SA
    Rathod, IS
    Savale, SS
    Kotecha, JS
    Shah, PB
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 190 (01) : 109 - 123
  • [34] Eudragit as the Material for the Production of Rifampicin and Isoniazid Microparticles
    Hwai, Ng Chai
    Gazzali, Amirah Mohd
    JOURNAL OF PHYSICAL SCIENCE, 2019, 30 : 221 - 233
  • [35] SIMULTANEOUS DETERMINATION OF ISONIAZID AND RIFAMPICIN BY UV PECTROPHOTOMETRY
    Tilinca, Mariana
    Hancu, Gabriel
    Mircia, Eleonora
    Iriminescu, Diana
    Rusu, Aura
    Vlad, Robert Alexandru
    Barabas, Eniko
    FARMACIA, 2017, 65 (02) : 219 - 224
  • [36] DISSOLUTION TEST METHOD FOR RIFAMPICIN ISONIAZID FIXED-DOSE FORMULATIONS
    JINDAL, KC
    CHAUDHARY, RS
    SINGLA, AK
    GANGWAL, SS
    KHANNA, S
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1994, 12 (04) : 493 - 497
  • [37] Challenges of therapeutic drug monitoring
    Labarde, Sebastien
    ACTUALITES PHARMACEUTIQUES, 2015, 54 (549): : 39 - 41
  • [38] Therapeutic drug monitoring of voriconazole
    Bruggemann, Roger J. M.
    Donnelly, J. Peter
    Aarnoutse, Rob E.
    Warris, Adilia
    Blijlevens, Nicole M. A.
    Mouton, Johan W.
    Verweij, Paul E.
    Burger, David M.
    THERAPEUTIC DRUG MONITORING, 2008, 30 (04) : 403 - 411
  • [39] Therapeutic drug monitoring in practice
    Hart, S.
    Hailwood, S.
    McLaren, J.
    SCOTTISH MEDICAL JOURNAL, 2019, 64 (03) : NP44 - NP44
  • [40] Therapeutic drug monitoring in tuberculosis
    Sarkar, M.
    Sarkar, J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 80 (11) : 1659 - 1684